If you notice facial changes with GLP-1 medications, treatments like dermal fillers or biostimulators (such as Sculptra) can help restore lost volume
Pharmacists and pharmacy technicians involved in compounding, compliance, or telehealth services, as well as healthcare professionals interested in GLP-1 and peptide therapies
Research has demonstrated superior weight reduction outcomes compared to dual-agonist peptides, with subjects showing significant reductions in body fat, improved insulin sensitivity, and favourable changes in lipid profiles
This isn't a slow, constant trickle
At 49, it went off the rails
Phase 3 TRIUMPH-4 results announced by Eli Lilly in December 2025 reported average weight loss of 71.2 lbs alongside significant relief from osteoarthritis pain, confirming that the Phase 2 efficacy signal translates to large-scale Phase 3 populations